![]()

New Arctic Blast Pain Relief topical formula combines menthol, camphor, aloe barbadensis, arnica montana flower extract, wintergreen oil, St. John’s wort oil and calendula officinalis extract in a cooling liquid drop applicator, with an ingredient-by-ingredient research overview
CAMAS, Wash., Sept. 20, 2026 — Nutriomo Labs Pte Ltd today announced the U.S. launch of Arctic Blast, its seven-ingredient topical cooling liquid formulated to provide temporary relief of occasional aches and discomfort in adults. The formula combines FDA-recognized topical active ingredients, essential oils and botanical extracts in a liquid drop format applied directly to the affected area and massaged gently into the skin. It is designed for adults seeking a topical option for occasional muscle and joint discomfort as part of a broader wellness routine.
The formula contains menthol, camphor, aloe barbadensis (aloe vera gel), arnica montana flower extract, wintergreen oil (methyl salicylate), St. John’s wort oil (Hypericum perforatum) and calendula officinalis extract. The recommended use is 3 to 4 drops applied to the affected area and massaged gently, at least twice daily or as needed. Arctic Blast is manufactured in the United States in a cGMP-certified facility using quality ingredients sourced globally. The formula is for external use only.
Alongside the launch, Arctic Blast is publishing an ingredient overview that summarizes published research on each component. The overview also explains where that research stops and what it does not establish about the finished product.
“Topical comfort products are often sold on bold promises built from loosely connected studies,” said Ryan Gray, Media Relations Manager at Arctic Blast. “We took the opposite approach. Arctic Blast is a straightforward topical formula, and we’re telling consumers exactly what’s in it, what the science on each ingredient actually shows, and where the evidence is still limited.”
A Seven-Ingredient Topical Formula for Temporary Relief of Occasional Aches and Discomfort
Arctic Blast’s formula draws from three ingredient categories, each associated with different aspects of topical comfort and skin function:
- FDA-recognized topical active ingredients: Menthol and camphor are both recognized by the U.S. Food and Drug Administration as OTC topical active ingredients for external analgesic and counterirritant use at approved concentrations. Wintergreen oil (methyl salicylate) is similarly recognized as a topical analgesic active ingredient at appropriate concentrations.
- Botanical skin-conditioning extracts: Aloe barbadensis, arnica montana flower extract and calendula officinalis extract contribute bioactive compounds studied in the context of skin hydration, normal skin barrier support and topical skin comfort.
- Complementary botanical oil: St. John’s wort oil contributes bioactive compounds with a recognized traditional use history in topical applications and a research profile in the context of skin-related wellness.
The combination reflects the company’s view that topical comfort involves multiple mechanisms — including counterirritant cooling, skin conditioning and normal inflammatory balance at the skin surface — rather than a single pathway. Arctic Blast emphasizes that this is a formulation rationale, not a clinical finding for the finished formula.
Menthol: An FDA-Recognized Topical Active Ingredient for Counterirritant and Analgesic Use
Menthol is a naturally occurring compound derived from peppermint and other mint oils, and one of the most widely used topical active ingredients globally. It produces a pronounced cooling sensation by activating TRPM8 cold-sensitive receptors in the skin without lowering actual tissue temperature. This counterirritant effect — whereby one sensation masks or reduces the perception of another — has been studied extensively in the context of topical comfort for muscle and joint discomfort.
Menthol is recognized by the FDA as an OTC topical active ingredient for external analgesic and counterirritant use at concentrations between 1.25% and 16% for counterirritant applications. Research has examined menthol’s relationship to normal pain perception and temporary comfort in several clinical and laboratory settings. Consumers are directed to the product label for the specific menthol concentration in Arctic Blast and its labeled indications for use. Its inclusion as the primary active ingredient reflects menthol’s well-established FDA-recognized role in topical comfort formulations.
Camphor: An FDA-Recognized Topical Active Ingredient for External Use
Camphor is a naturally occurring compound derived from the wood of Cinnamomum camphora, used in topical preparations for centuries. It produces a characteristic cooling-then-warming sensation on skin application and is recognized by the FDA as a topical OTC active ingredient for certain external analgesic and counterirritant uses at approved concentrations between 3% and 11%.
Camphor is a common ingredient in topical comfort formulations and has been studied for its counterirritant properties in both laboratory and clinical settings. Its mechanism of action is thought to complement menthol in topical formulas by extending the range of sensory counterirritant effects on the skin surface. Consumers are directed to the product label for the specific camphor concentration in Arctic Blast and labeled use directions.
Wintergreen Oil (Methyl Salicylate): An FDA-Recognized Topical Analgesic
Wintergreen oil is derived from the leaves of Gaultheria procumbens and contains a high concentration of methyl salicylate — a naturally occurring compound also found in small amounts in many plants and structurally related to aspirin (acetylsalicylic acid). Methyl salicylate is recognized by the FDA as a topical OTC analgesic active ingredient at approved concentrations and has a well-documented research history in topical comfort applications.
Research has examined methyl salicylate in the context of topical analgesic activity, where it is thought to work through both counterirritant effects and by penetrating the skin to produce localized analgesic activity. Consumers are directed to the product label for the specific methyl salicylate concentration in Arctic Blast, its labeled indications and any applicable safety information. Individuals with aspirin sensitivity or salicylate intolerance should consult a qualified healthcare professional before use.
Aloe Barbadensis (Aloe Vera): Research on Skin Hydration and Soothing Activity
Aloe vera (Aloe barbadensis miller) gel is among the most widely used botanical ingredients in topical formulations globally. Its bioactive compounds — including polysaccharides, glycoproteins and vitamins — have been studied for their relationship to normal skin hydration, soothing of irritated skin and normal skin barrier support.
A systematic review of published research on aloe vera in topical applications noted associations between aloe vera gel and improvements in skin hydration and normal skin barrier support in several study populations. These findings describe aloe vera’s interaction with skin surface markers in controlled conditions and do not establish outcomes from the finished Arctic Blast formula. Its inclusion reflects aloe vera’s well-documented research profile as a topical skin-conditioning ingredient, not a product-specific clinical claim.
Arnica Montana Flower Extract: Research on Topical Skin Comfort and Moisturizing Activity
Arnica montana is a flowering plant native to mountainous regions of Europe and North America, whose flower extracts have been used in traditional European herbal medicine for centuries. Its bioactive compounds — including sesquiterpene lactones such as helenalin — have attracted research interest for their relationship to topical skin comfort and normal skin inflammatory balance.
A body of research has examined arnica montana extract in topical formulations in the context of skin comfort and moisturizing activity. The European Medicines Agency has recognized arnica montana as a traditional herbal medicinal product for topical use in the context of local mild muscle and joint discomfort, based on traditional use evidence. These findings describe arnica’s interaction with skin surface markers and do not establish outcomes from the finished Arctic Blast formula. Its inclusion reflects the recognized traditional use history and research profile of arnica montana in topical skin comfort formulations, not a product-specific clinical claim.
St. John’s Wort Oil: Research on Topical Skin-Related Wellness
St. John’s wort (Hypericum perforatum) oil is derived from the flowers and leaves of the plant steeped in a carrier oil. It is distinct from standardized St. John’s wort oral supplements and has a recognized traditional use history in European herbal medicine for topical application in the context of skin wellness.
Research has examined St. John’s wort oil in the context of topical skin-related applications, including normal skin comfort and skin surface support. A review published in the Journal of Pharmacy and Pharmacology examined evidence for topical hypericum preparations and noted associations with improvements in skin comfort markers in several study populations. These findings describe how St. John’s wort oil interacts with skin surface markers in research conditions and do not establish outcomes from the finished Arctic Blast formula. Its inclusion reflects the recognized traditional use history of St. John’s wort oil in topical formulations, not a product-specific clinical claim.
Calendula Officinalis Extract: Research on Skin Soothing and Normal Barrier Support
Calendula (Calendula officinalis) flower extract is widely used in topical formulations and has a recognized place in European phytomedicine for skin wellness applications. Its bioactive compounds — including flavonoids, triterpenoids and polysaccharides — have been studied for their relationship to normal skin soothing, skin barrier support and normal wound healing processes.
A systematic review of published evidence on calendula in topical applications noted associations between calendula preparations and improvements in skin comfort and barrier markers in several study populations. These findings describe calendula’s interaction with skin surface markers in controlled conditions and do not establish outcomes from the finished Arctic Blast formula. Its inclusion reflects the recognized research profile of calendula officinalis extract in topical skin-conditioning formulations, not a product-specific clinical claim.
What Ingredient Research Does and Does Not Show
Arctic Blast’s research overview separates three questions: what each ingredient is, what researchers have studied about it, and what has been demonstrated about the finished formula. Those questions have different answers.
The studies referenced here examined individual ingredients at specific concentrations, in specific conditions and over specific periods. Arctic Blast combines seven ingredients in a single topical formula, and the concentrations, preparations and interactions within that formula differ from the conditions of any individual study. For that reason, Arctic Blast does not describe its formula as clinically proven and does not attribute ingredient-level research results to the finished product.
“We think consumers respond better to honesty than hype,” said Ryan Gray. “Every ingredient in Arctic Blast has a recognized role in topical formulations or an active research profile. What we won’t do is stretch a study beyond what it found.”
Safety and Suitability
Arctic Blast is a topical formula intended for external use only in healthy adults aged 18 and over. It is not for oral consumption. Avoid contact with eyes and mucous membranes; wash hands thoroughly with soap and water after each application. Do not apply to broken, damaged or irritated skin.
Individuals with aspirin sensitivity or salicylate intolerance should consult a qualified healthcare professional before use, given the presence of methyl salicylate (wintergreen oil). Individuals with known sensitivity to any listed ingredient should discontinue use and consult a qualified healthcare professional if irritation, redness or adverse skin reaction occurs.
Arctic Blast is intended for temporary relief of occasional aches and discomfort. It is not a substitute for professional medical evaluation of persistent, worsening or unexplained pain. Persistent or severe discomfort should be evaluated by a qualified healthcare professional. The same consultation applies to individuals who are pregnant, nursing, managing a medical condition or taking prescription medication. Keep out of reach of children. The physical label is the definitive source for directions, warnings and ingredient concentrations.
Product Format and Availability
Arctic Blast Pain Relief is available now to consumers across the United States through the company’s official website at getarcticblast.com. The recommended use is 3 to 4 drops applied to the affected area and massaged gently, at least twice daily or as needed. Manufactured in the United States in a cGMP-certified facility using quality ingredients sourced globally. All orders are backed by a 365-day money-back guarantee.
Under U.S. federal law, topical OTC products containing active ingredients at approved concentrations (such as menthol, camphor and methyl salicylate) are subject to FDA monograph standards rather than pre-market approval. Consumers are directed to the product label for confirmed active ingredient concentrations and labeled indications.
About Arctic Blast and Nutriomo Labs
Arctic Blast was developed with the principle that topical comfort formulations should combine FDA-recognized active ingredients with complementary botanical skin-conditioning extracts, disclosed transparently on the label and represented accurately — without overstating what individual ingredient studies show about a finished multi-ingredient topical formula. Nutriomo Labs’ mission is to offer adults a topical comfort option that draws on recognized counterirritant, analgesic and botanical research traditions, manufactured to quality standards and supported by honest communication about what the science does and does not establish. Every ingredient in Arctic Blast is selected on the basis of its FDA-recognized status, its published research profile or its recognized traditional use history in topical formulations.
Arctic Blast holds itself to three standards: complete ingredient disclosure on the product label, manufacturing in a cGMP-certified U.S. facility using globally sourced quality ingredients, and accurate representation of the research behind each component — including its limits. The Arctic Blast Pain Relief formula combines menthol, camphor, aloe barbadensis, arnica montana flower extract, wintergreen oil, St. John’s wort oil and calendula officinalis extract in a topical liquid drop applicator. For external use only. More information is available at getarcticblast.com.
References
- Pergolizzi JV, Taylor R, LeQuang JA, et al. The role and mechanism of action of menthol in topical analgesic products. Journal of Clinical Pharmacy and Therapeutics. 2018;43(3):313–319.
- Muto T, Chian YY, Watanabe T, et al. Effect of menthol on the skin and mucous membranes. Journal of the Pharmaceutical Society of Japan. 2022.
- Woolf CJ. Central sensitization: implications for the diagnosis and treatment of pain. Pain. 2011;152(3 Suppl):S2–S15.
- Surjushe A, Vasani R, Saple DG. Aloe vera: a short review. Indian Journal of Dermatology. 2008;53(4):163–166.
- Iannitti T, Morales-Medina JC, Bellavite P, et al. Effectiveness and safety of arnica montana in post-surgical setting, pain and inflammation. American Journal of Therapeutics. 2016;23(1):e184–e197.
- Schempp CM, Windeck T, Hezel S, et al. Topical treatment of atopic dermatitis with St. John’s wort cream — a randomized, placebo-controlled, double-blind half-side comparison. Phytomedicine. 2003;10 Suppl 4:31–37.
- Preethi KC, Kuttan G, Kuttan R. Anti-inflammatory activity of flower extract of Calendula officinalis Linn. and its possible mechanism of action. Indian Journal of Experimental Biology. 2009;47(2):113–120.
Media Contact
Ryan Gray, Media Relations Manager
Arctic Blast
/ Nutriomo Labs Pte Ltd
3242 NE 3rd Avenue #1043, Camas, WA 98607, USA
Email: support@getarcticblast.com
Phone: +1 251-501-2766
Website: getarcticblast.com
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Research cited in this release pertains to individual ingredients studied in isolation; it does not represent clinical evaluation of the Arctic Blast formula as a finished product, nor does it constitute endorsement by the referenced researchers, journals or institutions. Arctic Blast is for external use only and is not a substitute for professional medical evaluation of persistent or severe pain.
The post Arctic Blast Reviews: Nutriomo Labs Launches Seven-Ingredient Topical Cooling Liquid for Temporary Relief of Occasional Aches and Discomfort in the U.S. appeared first on 24 Health Times.